BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1206 related articles for article (PubMed ID: 28734987)

  • 1. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome.
    Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M
    Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome.
    Mesinovic J; Teede HJ; Shorakae S; Lambert GW; Lambert EA; Naderpoor N; de Courten B
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
    Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
    Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
    Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
    Santos BR; Lecke SB; Spritzer PM
    PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity.
    Tsakova AD; Gateva AT; Kamenov ZA
    Int J Vitam Nutr Res; 2012 Dec; 82(6):399-404. PubMed ID: 23823925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
    Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
    Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.
    Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E
    Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.
    Mahmoudi T; Gourabi H; Ashrafi M; Yazdi RS; Ezabadi Z
    Fertil Steril; 2010 Mar; 93(4):1208-14. PubMed ID: 19230880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
    Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.